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Abstract
Background: The genus Micrurus, coral snakes (Serpentes, Elapidae), comprises more than 120 species and
subspecies distributed from the south United States to the south of South America. Micrurus snake bites can cause
death by muscle paralysis and further respiratory arrest within a few hours after envenomation. Clinical
observations show mainly neurotoxic symptoms, although other biological activities have also been experimentally
observed, including cardiotoxicity, hemolysis, edema and myotoxicity.
Results: In the present study we have investigated the action of venoms from seven species of snakes from the
genus Micrurus on the complement system in in vitro studies. Several of the Micrurus species could consume the
classical and/or the lectin pathways, but not the alternative pathway, and C3a, C4a and C5a were generated in sera
treated with the venoms as result of this complement activation. Micrurus venoms were also able to directly cleave
the a chain of the component C3, but not of the C4, which was inhibited by 1,10 Phenanthroline, suggesting the
presence of a C3a chain specific metalloprotease in Micrurus spp venoms. Furthermore, complement activation
was in part associated with the cleavage of C1-Inhibitor by protease(s) present in the venoms, which disrupts
complement activation control.
Conclusion: Micrurus venoms can activate the complement system, generating a significant amount of
anaphylatoxins, which may assist due to their vasodilatory effects, to enhance the spreading of other venom
components during the envenomation process.
Background
The Elapidae family is represented in America by three
genera of coral snakes: Micruroides, Leptomicrurus and
Micrurus, the latter being the most abundant and diverse
group. In Brazil, M. corallinus and M. frontalis are
responsible for the majority of coral snake envenoma-
tions. Although, Micrurus bites are relatively rare, the
accidents can cause death, by muscle paralysis and
respiratory arrest, few hours after envenomation [1].
The main feature of the coral snake action is the neuro-
toxicity, although, experimentally, it has been documented
that some Micrurus venoms may produce myotoxicity and
local lesions [2,3]. Furthermore, many enzymatic activities
were detected in Micrurus venoms including phospholi-
pase A2, hyaluronidase, phosphodiesterase, leucine amino
peptidase, L-amino acid dehydrogenase and L-amino acid
oxidase activities [4-6]. Only little or no proteolytic effects
have been detected in Micrurus venoms [5,6].
Previously, we have analyzed the pro-inflammatory
properties of the snake venoms from the Elapidae family,
including the genera Micrurus (M. ibiboboca and
M. spixii) and Naja (N. naja, N. melanoleuca and
N. nigricollis), and demonstrated that these snake venoms
can activate the complement system in normal serum [7].
The electrophoretic conversion of C3 was observed with
all venoms in human normal serum containing normal
concentrations of Ca2+ and Mg2+. However when Ca2+
was chelated the conversion of C3 was only observed in
serum incubated with the N. naja and N. melanoleuca
venoms. Purified human C3 was electrophoretically con-
verted, in the absence of other complement system com-
ponents, by the venoms from N. naja, N. nigricollis and
M. ibiboboca. However, only the venoms from N. naja
and N. melanoleuca contained a 144 kDa protein
* Correspondence: dvtambourgi@butantan.gov.br
1Immunochemistry Laboratory, Butantan Institute, Av. Vital Brazil, 1500, São
Paulo, 05503-900, Brazil
Full list of author information is available at the end of the article
Tanaka et al. BMC Immunology 2012, 13:4
http://www.biomedcentral.com/1471-2172/13/4
© 2012 Tanaka et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
recognized by anti-sera against cobra venom factor or
human C3.
The complement system (C) consists of three activation
pathways, i.e., classical (CP), alternative (AP) and lectin
(LP) pathways, which converge at the proteolytic activa-
tion step of C3, the central component of the complement
system. Complement activation may generate anaphyla-
toxins and membrane attack complex (MAC). Anaphyla-
toxins (C3a, C4a, and C5a) are considered the bridge
between the innate and adaptive immunity, and they are
responsible for control the local pro-inflammatory
response through vasodilatation and the chemotaxis and
activation of leukocytes [8-11]. The regulatory mechan-
isms of complement are extremely balanced, controlled by
several complement inhibitors, such as membrane-bound
complement regulators, and plasma proteins like C1-ester-
ase inhibitor (C1-INH), which regulates activation of C1
and MASPs of the classical and lectin complement path-
ways, among others [8,12,13].
The complement system not only plays an important
role in the defense system, but also contributes to the
amplification of inflammation if activated in excess or
inappropriately controlled. The best-characterized venom
that has a complement activating substance is that of the
Cobra (Naja naja, Elapidae). Cobra venom contains a
C3-like molecule named Cobra venom factor (CVF),
which can initiate the alternative pathway by forming
with factor B an extremely stable C3/C5 convertase and
the consequence of this is excess C5a generation and C-
consumption [14-16]. We have recently investigated the
complement activating properties of snake venoms of the
Bothrops genus and found that several venoms caused
complement activation [17]. The aim of the present
study was to further investigate the action of snake
venoms from the genus Micrurus, occurring in Brazil, on
the activation pathways and components of the comple-
ment system.
Results
Action of Micrurus spp venoms on the complement
system activation pathways
In order to evaluate the possible action of Micrurus spp
venom toxins on the complement system, samples of nor-
mal human serum were incubated with PBS or the
venoms and the remaining complement lytic activity was
measured under conditions to develop the classical, alter-
native or lectin pathways. Figure 1A shows that the
venoms from M. ibibococa, M. altirostris, M spixii and
M. frontalis induced a significant reduction of the classical
complement pathway lytic activity, as measured in haemo-
lytic assays using antibody-sensitized sheep erythrocytes.
Analysis of the activity of Micrurus spp venoms on the lec-
tin pathway showed that M. ibiboboca, M. lemniscatus,
M. altirostris, M. surinamensis and M. corallinus snake
venoms induced a low but significant reduction of the LP
activity (Figure 1B). No action was observed of Micrurus
spp venoms on the alternative pathway (data not shown).
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Figure 1 Action of Micrurus spp venoms on the complement
pathways. Samples (50 μl) of normal human serum (NHS), as
complement source, were incubated with 50 μl of Micrurus spp
venoms (50 μg) or PBS for 30 min at 37°C. The residual
complement lytic activity of the mixtures was measured using
antibody-sensitized sheep erythrocytes, as targets, for classical
pathway [A]. After incubation for 1 h at 37°C, the absorbance of the
supernatants was measured at l414 nm and the percentage of
haemolysis calculated. The residual lectin pathway complement
activity [B] was determined on ELISA plates coated with mannan.
Data are representative for three separate experiments and
expressed as mean of duplicates +/-SD. Results were expressed as
reduction of percentage of haemolysis [for A] or reduction of C4
binding [B] in relation to the control samples (NHS + buffer).
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To investigate if the decrease in the pathways activities,
induced by Micrurus venoms, could be due to the pre-
sence of Cobra Venom Factor (CVF) like components,
venoms were analyzed by western blotting using an anti-
serum raised against CVF from N. naja. Figure 2 shows
that CVF components were clearly detected in N. naja
and N. melanoleuca venoms. On the other hand, no CVF
antigenically related components were detected in
N. nigricollis, N. mossambica or Micrurus spp venoms.
Induction of the anaphylatoxins by Micrurus spp venoms
To assess if the above observed reduction in comple-
ment activities was caused by C-inhibition or C-activa-
tion/consumption, the generation of C-activation
products C3a, C4a and C5a was measured. Figure 3
shows that the majority of Micrurus spp venoms
induced the production of significant amounts of the
three anaphylatoxins. M. corallinus venom did not
induce C5a release, but considerable amounts of C3a
and C4a. These data suggest that the reduction in CP
and LP, as observed above, is due to C-activation/con-
sumption rather that C-inhibition.
Micrurus spp venoms cleave the C3a chain
In order to analyze the possibility of direct proteolytic
action of Micrurus venoms on the complement molecules,
purified samples of C3 were incubated with the venoms
and analyzed by western blot for the presence of cleavage
fragments. Figure 4A shows that the venoms from M. ibi-
boboca, M. lemniscatus, M. corallinus, M. frontalis were
able to induce cleavage of the C3 a chain (Mr ~115 kDa),
but not of the b chain, generating a fragment with an
Figure 2 Analysis of the presence of CVF components in
Elapidae snake venoms. Samples of 10 μg of the Micrurus spp
and Naja spp venoms were solubilised in non-reducing sample
buffer and run on 10% SDS-PAGE gel. The presence of CVF
components was evaluated by Western blot using anti-CVF rabbit
antiserum, diluted 1:1500.
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Figure 3 Generation of human serum anaphylatoxins induced
by Micrurus spp venoms. Samples (50 μl) of normal human serum
(NHS), as complement source, were incubated with 50 μl of
Micrurus spp venoms (50 μg) or PBS for 30 min at 37°C. The
generation of the anaphylatoxins (C3a, C4a and C5a) in the serum
samples was measured by Cytometric Bead Array. Data are
representative for three separate experiments and expressed as
mean of duplicates +/-SD; results were expressed as concentration
of each anaphylatoxin per mL of human serum.
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estimated Mr of 107 kDa. The C3 a chain cleavage,
induced by the venoms, could be prevented by the use of
1,10 phenanthroline, a metalloproteinase inhibitor (Figure
4B), but not by PMSF, a serineprotease inhibitor (Figure
4C). Analysis of the Micrurus venoms action on purified
human C4 showed that all venoms were unable to induce
cleavage of the a, b or g chains (data not shown).
Micrurus spp venoms induce cleavage of the C1-Inhibitor
Since the majority of Micurus venoms could interfere
with the classical and/or lectin pathways, we have inves-
tigated if the complement regulator of activation of
these pathways, C1-INH, would have undergone to clea-
vage. Figure 5A shows that all venoms induced cleavage
of C1-INH, generating a main fragment of approxi-
mately 83 kDa. The fragmentation could be totally
blocked by incubating venoms and C1-INH samples in
the presence of 1,10 phenanthroline; PMSF could only
partially abolish the cleavage of C1-INH induced by
M. ibiboboca venom (Figure 5B and 5C).
Discussion
The toxins present in venoms, used by snakes for effective
immobilization of prey and for protection against preda-
tors, must rapidly reach the target organs. Therefore,
mechanisms facilitating the distribution of the toxins
throughout the tissues of the bitten animal must be acti-
vated. Hyaluronidase, which is present in almost all
venoms, was the first of such mechanisms to be described
[18]. Another mechanism which could fulfill this spreading
function is local acute inflammation at the site of bite.
Some potentially pro-inflammatory factors such as proteo-
lytic enzymes and activators of clotting, complement and
kallikrein-kinin systems have been detected in Crotalidae
and Viperidae venoms. The action of these factors on the
corresponding host substrates may release endogenous
mediators of inflammation [14,19-22].
The Elapidae venoms analyzed in the present study from
Micrurus genus were also able to activate the complement
system. M. ibiboboca and M. altirostris venoms affected
classical and lectin pathways; M. spixii and M. frontalis
venoms affected only the classical pathway and M. lemnis-
catus, M. surinamensis and M. corallinus venoms only the
lectin pathway. These differences of Micrurus spp venoms
action on the complement system may be due to interspe-
cies variations in venom composition. Indeed, previous
results of our group [6] showed that venoms from these
Micrurus species differ in protein composition and toxic
potential, probably associated with the geographical origin,
habitat and diet of the snakes.
The majority of the Micrurus spp venoms induced the
production of significant amounts of the three anaphyla-
toxins C3a, C4a and C5a. This suggests that these venoms
Figure 4 Proteolytic action of the Micrurus spp venoms on
human purified C3. [A] Samples of purified component C3 (1 μg)
were incubated with 2 μg of Micrurus spp venoms or PBS for 30
min at 37°C. Inhibition assays were performed by including 10 mM
of 1,10 phenanthroline [B] or PMSF [C] in the mixtures. Cleavage
was visualized by western blot using anti-C3 serum.
Figure 5 Proteolytic action of the Micrurus spp venoms on
human purified C1-INH. [A] Samples of purified component C1-
INH (1 μg) were incubated with 2 μg of Micrurus spp venoms or
PBS for 30 min at 37°C. Inhibition assays were performed 10 mM of
1,10 phenanthroline [B] or PMSF [C] in the mixtures. Cleavage of
C1-INH was visualized by western blot using anti-C1-INH serum.
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are able to activate the complement system and that the
observed reduction of the CP and LP complement activ-
ities, after treatment with the various venoms, was most
likely caused by activation of the pathways, resulting in
consumption of the C-components; however some inacti-
vation/inhibition of C-components may also have
occurred.
The action of cobra venom factor (CVF) from the cobra
Naja naja, as a complement activator and generator of
anaphylatoxins, has been well described [14-16]. In the
present study, the presence of CVF-like molecules was not
detected in Micrurus spp venoms, using antibodies against
N. naja CVF in western blot assays. These results may
suggest that CVF components are not present in the
Micrurus venoms here studied or that they do not share
the same antigenic properties.
Analysis of a possible direct proteolytic action of
Micrurus venoms on the complement molecules showed
that, using purified C3, cleavage was induced by M. ibi-
boboca, M. lemniscatus, M. corallinus, M. frontalis but
not by M. altirostris, M. spixii and M. surinamensis. C3
proteolytic activity in snake venoms from the Elapidae
family has been previously reported by O’Keefe and col-
laborators [23] in Naja naja siamensis and by us in
N. naja, N. nigricollis and M. ibiboboca [7], although no
further characterization of the class of protease involved
has been performed. In the present study, we have
shown that metalloproteinases are the main proteases
responsible for this event, since the specific inhibitor,
1,10 phenathroline, completely abrogated the C3a chain
hydrolysis induced by Micrurus venoms, thus, possibly
contributing to the activation and inactivation of the
complement activation pathways, as well as to the gen-
eration of the anaphylatoxins. On the other hand, no
cleavage of C4 was observed, suggesting the presence of
a specific C3 a chain cleaving metalloprotease in some
Micrurus venoms.
The majority of the Micrurus spp venoms induced con-
sumption of the classical and or the lectin pathways and
we investigated the mechanism of this. The presence of
antibodies as initiating factor was discarded, since the
human serum samples used were devoid of Micrurus spp
venoms specific antibodies (data not shown). Another pos-
sibility investigated was the failure of the complement reg-
ulatory mechanisms. C1-INH is the primary regulator of
the activation of the classical and lectin pathways and also
plays an important role in the regulation of coagulation
and fibrinolysis. C1-INH inactivates C1r and C1s, the ser-
ine protease subcomponents of the first component of the
classical pathway, and MASP 1 and 2 proteases of the lec-
tin pathway; removal/inactivation of C1-INH leads to
auto-activation of the CP and LP. We show here that all
Micrurus venoms were able to cleave the C1-INH, gener-
ating a fragment of approximately 83 kDa, and this
hydrolysis could be blocked by metalloproteinase inhibi-
tors 1,10 phenanthroline. PMSF could partially abolish the
cleavage of C1-INH induced by M. ibiboboca venom.
Cleavage of C1-INH by Crotalid, Viperid and Colubrid
snake venoms has previously been reported by Kress et al.
[24], who demonstrated that the inhibitor was converted
into an active intermediate species of 89-kDa and then a
further cleavage resulted in formation of an 86-kDa inac-
tive inhibitor. We have recently demonstrated that venoms
snakes from Bothrops genus were also able to cleave C1-
INH, generating a main fragment of approximately 83 kDa
[17] and this fragmentation could be totally blocked by
1,10 phenanthroline. These data suggest that the different
families of snakes may possess common factor(s) in their
venoms allowing them to inactivate C1-INH, which may
lead to unrestricted activation of both coagulation and
complement cascades and participate in the mediation of
the toxic effects of the venoms.
Conclusion
Data presented here demonstrate that Micrurus venoms
can activate the complement system, generating significant
amounts of anaphylatoxins, which may assist, due to their
vasodilatory effects, to enhance the spreading of other
venom components.
Methods
Chemicals and reagents
Tween 20, bovine serum albumin (BSA), ortho-phenylene-
diamine (OPD), phenylmethylsulfonyl fluoride (PMSF),
1,10 phenanthroline, ethylene diamine tetracetic acid
(EDTA), ethylene glycol bis-(b-aminoethyl ether)-N, N, N,
N’-tetracetic acid (EGTA) and mannan were purchased
from Sigma (St. Louis, Missouri, USA). Goat anti-rabbit
(GAR) and rabbit anti-goat (RAG) IgG labelled with alka-
line phosphatase (IgG-AP) or with horseradish peroxidase
(IgG-HRPO), 5-bromo-4-chloro-3-indolyl-phosphate
(BCIP) and nitroblue tetrazolium (NBT) were from Pro-
mega Corp. (Madison, Wisconsin, USA). Purified human
C3 and C4, and goat IgG anti-human C4 were from Qui-
dell Corporation (San Diego, CA, USA). Purified human
C1-INH and rabbit IgG anti-C1-INH were from Calbio-
chem-Novabiochem Corp. (San Diego, CA, USA). Rabbit
IgG anti-C3 was from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA, USA) and rabbit polyclonal serum
against sheep erythrocytes was made in house. Polyclonal
rabbit antiserum against Naja naja cobra venom factor
(CVF) was a kind donation from Dr. Carl Wilhelm Vogel,
Honolulu, Hawaii, USA.
Venoms
Venoms from Micrurus ibiboboca, M. lemniscatus,
M. altirostris, M. spixii, M. surinamensis, M. corallinus,
M. frontalis, Naja naja, Naja nigricollis, Naja mossambica
Tanaka et al. BMC Immunology 2012, 13:4
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and Naja melanoleuca were supplied by Herpetology
Laboratory from Butantan Institute, SP, Brazil. Stock solu-
tions were prepared in PBS (10 mM sodium phosphate
containing 150 mM NaCl, pH 7.2) at 1.0 mg/mL. The per-
mission to access venoms from Micrurus spp snakes (per-
mission no. 01/2009) was provided by the Brazilian
Institute of Environment and Renewable Natural
Resources (IBAMA).
Human serum and erythrocytes
Human blood was obtained from healthy donors. Blood
samples drawn to obtain sera were collected without antic-
oagulant and allowed to clot for 2 h at room temperature;
the normal human serum (NHS) was stored at -80°C.
Blood samples from sheep or rabbit, drawn to obtain ery-
throcytes for subsequent use as target cells, were collected
in anticoagulant (Alsever’s old solution: 114 mM citrate,
27 mM glucose, 72 mM NaCl, pH 6.1). The human blood
samples in this study were obtained from three healthy
donors in our research group who clearly knew the pur-
pose of this study, according to the Blood Donation Law
of Brazil. This study was approved by the ethics committee
of Butantan Institute.
Treatment of the normal human serum with Micrurus spp
venoms
Samples of 50 μl of normal human serum (NHS) were
incubated with 50 μl (50 μg) of Micrurus spp venoms or
PBS. The mixtures were incubated for 30 min at 37°C and
tested for the residual complement activity in hemolytic
assays (for classical and alternative pathways measure-
ments) or by ELISA (for lectin pathway evaluation).
Haemolytic complement activity
For classical pathway analysis, sheep erythrocytes were
washed in PBS and a 2% suspension was incubated with
an equal volume of a 1:500 dilution in PBS of rabbit anti-
sheep erythrocytes serum for 15 min at 37°C. The anti-
body-sensitized sheep erythrocytes were washed and
resuspended in veronal buffered saline (VBS++: 3.7 mM
Barbitone, 0.3 mM CaCl2 and 0.8 mM MgCl2, 145.5 mM
NaCl, pH 7.2) at 2% final concentration. For alternative
pathway analysis, rabbit erythrocytes were washed in PBS
and resuspended in AP buffer (5 mM Na-barbital, 10 mM
EGTA, 7 mM MgCl2; 150 mM NaCl, pH 7.4) at 2% final
concentration. The antibody-sensitized sheep erythrocytes
or the rabbit erythrocytes (50 μl) were added to each well,
of a 96-well plate, and incubated, for 30 min at 37°C, with
venom- or PBS-treated NHS samples. For each sample to
be tested doubling dilutions in VBS++ were made (150 μl/
well), including zero and 100% lysis wells. Unlysed cells
were removed by centrifugation at 1300 rpm at 4°C for
5 min. Fifty microlitres of each supernatant were trans-
ferred to new 96-well plates containing 200 μl of water,
and the absorbance measured at 414 nm as an index of
hemolysis. Percentage of hemolysis for each well and the
number of CH50 and AP50 for each serum were calculated
by standard methods.
Complement activation of the lectin pathway as
determined by ELISA
Microtitre plates were coated with 10 μg/well of mannan,
overnight at 4°C, washed three times with PBS/0.05%
Tween 20, and blocked using 1% BSA in PBS for 30 min
at 37°C. After washing, serial dilutions of NHS samples
treated with PBS or Micrurus spp venoms were added.
After 1 h of incubation at 37°C, plates were washed with
BVB++ (VBS++, pH 7.2, containing 0.1% BSA) and incu-
bated with anti-human C4 (1:2.000) for 1 h at 37°C. Plates
were washed three times with BVB++/Tween 0.05% and
incubated with the specific anti-IgG antibody conjugated
with HRPO for 1 h. Plates were washed and the reactions
developed with OPD substrate according to the conditions
established by the manufacturers (Sigma). The absor-
bances were recorded in an ELISA reader (Multiskan spec-
trophotometer EX, Labsystems, Finland) at l492 nm. For
complement activity ELISA, normal human serum arbitra-
rily set at 1000 aU/ml, was used to produce a calibration
curve.
Detection of Anaphylatoxins
Samples of normal human serum (50 μL) were incubated
with PBS (50 μL) or with Micrurus spp venoms (50 μL =
50 μg) for 30 min at 37°C, and C3a/C3a desArg, C4a/C4a
desArg, and C5a/C5a desArg concentrations were mea-
sured using the Cytometric Bead Array (BD Biosciences
Pharmingen, New Jersey, California, USA). Anaphyla-
toxin capture beads were incubated with the standards or
with the test samples, washed, and then incubated with
phycoerythrin-conjugated detection antibodies to form
sandwich complexes. Two-color flow cytometric analysis
was performed using a FACSCalibur flow cytometer
(Becton Dickinson Immunocytometry Systems, Santa
Clara, California, USA). Data were acquired and analyzed
using Becton Dickinson Cytometric Bead Array CBA
software. Anaphylatoxin concentrations were determined
from the standard curves, plotting anaphylatoxin calibra-
tor concentration versus FL-2 mean fluorescence
intensity.
Proteolytic activity of Micrurus spp venoms on the
complement molecules
Venoms samples (1 μg) were incubated with the human
purified components C3, C4 or C1-INH (2 μg) in PBS
for 30 min at 37°C, and the cleavage was detected by
western blotting. 20 mM of PMSF or phenanthroline,
inhibitors of serine- and metallo-proteases, respectively,
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were added to assess the nature of the cleaving enzyme
in the venom.
Electrophoresis and western blot
Samples were solubilised in reducing or non-reducing
sample buffers and separated in 10% SDS-PAGE gels
[25]. Gels were blotted onto nitrocellulose [26]. After
transfer, the membranes were blocked with PBS con-
taining 5% BSA for 2 h and incubated with anti-C3
(1:5000), anti-C4 (1:1000), anti-C1-INH human (1:2000)
or anti-CVF (1:1500) sera, for 1 h at room temperature.
Immunoreactive proteins were detected using GAR/IgG-
AP or RAG/IgG-AP (1:7500) in PBS/1% BSA for 1 h at
room temperature. After washing 3 times, for 10 min
with PBS/0.05% Tween 20, blots were developed using
NBT/BCIP according to the manufacturer’s instructions
(Promega).
Abbreviations used
C: Complement system; CP: classical pathway; AP: alter-
native pathway; LP: Lectin pathway; C1-esterease Inhibi-
tor: C1-INH; CVF: cobra venom factor; NHS: normal
human serum.
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